LYEL logo

Lyell Immunopharma Inc

LYEL

$2.44

+ $0.30 (14.02%) This month

Closed: 22 Feb 2024 21:00 US/Eastern

Key details

CEO

-

Employees

272

Headquarters

null, null

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

About Lyell Immunopharma Inc

we are entering a new era of medicine, where cancer is treated with cellular therapies: living, smart, targeted drugs. while enormous strides have been made, especially in hematologic cancers, the full promise of these therapies still lies ahead. cell-based immunotherapies have yet to show substantial benefit in solid tumors, which represent the vast majority of cancers. our goal is nothing less than to develop curative cell-based immunotherapies for any cancer, with a focus on car-ts and solid tumors.

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG